2.4
Instructions for Use & Clinical Reference Manual (US)
Minimize exposure of Impella
®
System components to sources of electromagnetic
interference (EMI). Exposure to sources of EMI, such as cell phones and two-way
radios, may cause operational interference. To clear interference, either increase the
distance between system components and the EMI source or turn off the EMI source.
During use with the Remote Link, a Medical Device Data System (MDDS), if the
Automated Impella
®
Controller is exposed to strong electromagnetic disturbances,
the Remote Link may either restart or shut down. Operators should be aware that,
under these conditions, the Automated Impella
®
Controller operating parameters
are not affected. If the Remote Link stops working because of electromagnetic
disturbances, a hard restart (by first disconnecting, and then reconnecting its AC
power) will correct the problem.
Operation of Impella
®
System components may interfere with the operation of other
devices. If interference occurs, increase the distance between the device and system
components.
Have a backup Automated Impella
®
Controller, purge cassette, connector cable,
and Impella
®
Catheter available in the unlikely event of a device failure.
Do
NOT
use the bed mount as a handle.
Do
NOT
alter the Impella
®
Introducer kit in any way.
Aspiration and saline flushing of the Impella
®
Introducer kit sheath, dilator, and
valve should be performed to help minimize the potential for air embolism and clot
formation.
Indwelling introducer sheaths should be internally supported by a catheter or
dilator.
Dilators and catheters should be removed slowly from the sheath. Rapid removal
may damage the valve, resulting in blood flow through the valve.
Never advance the guidewire or sheath when resistance is met. Determine the
cause of resistance using fluoroscopy and take remedial action.
When injecting or aspirating through the sheath, use the sideport only.
Operation of the system without heparin in the purge solution has not been
tested. In the event that a patient is intolerant to heparin, due to heparin-induced
thrombocytopenia or bleeding, physicians should use their clinical judgment to
assess the risks versus benefits of operating the Impella
®
System without heparin.
If it is in the best interest of the patient to operate the system without heparin, the
dextrose solution is still required, and physicians should consider systemic delivery
of an alternative anticoagulant. Do
NOT
add any alternative anticoagulant (such as
a direct thrombin inhibitor) to the purge fluid. The Impella
®
Catheter has not been
tested with any alternative anticoagulants in the purge solution.
Summary of Contents for Impella 2.5
Page 4: ......
Page 8: ......
Page 10: ......
Page 12: ......
Page 15: ...2 WARNINGS AND CAUTIONS WARNINGS 2 1 CAUTIONS 2 3...
Page 16: ......
Page 22: ......
Page 38: ......
Page 40: ......
Page 108: ......
Page 171: ......
Page 173: ......
Page 181: ......
Page 183: ......
Page 201: ......
Page 203: ......
Page 205: ......
Page 210: ...INDEX TBD...